<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04648540</url>
  </required_header>
  <id_info>
    <org_study_id>MD-242-2019</org_study_id>
    <nct_id>NCT04648540</nct_id>
  </id_info>
  <brief_title>Multimodal Opioid-free Anesthesia Versus Opioid-based Anesthesia for Patients Undergoing Cardiac Valve Surgeries: RCT</brief_title>
  <official_title>Multimodal Opioid-free Anesthesia Versus Opioid-based Anesthesia for Patients Undergoing Cardiac Valve Surgeries: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several studies demonstrated the effectiveness of OFA in patients undergoing non-cardiac&#xD;
      surgery. Preoperative use of Cox inhibitors, GABA analogues and acetaminophen have been shown&#xD;
      to decrease use of opioids postoperatively . Intraoperative use of agents that lead to opioid&#xD;
      sparing effects via sodium channel blockade, blockade of G protein-coupled receptors, NMDA&#xD;
      blockade, central alpha-2 agonists and anti-inflammatory effects can make opioid-free&#xD;
      anesthesia (OFA) possible. On the other hand, there have been no studies demonstrating the&#xD;
      effectiveness of an OFA technique in patients undergoing cardiac surgery except for two case&#xD;
      reports who successfully implemented the OFA regimen in two patients undergoing valve&#xD;
      replacement surgeries. The investigators therefore propose this prospective randomized&#xD;
      controlled trial to investigate whether a multimodal opioid-free anesthesia regimen will be&#xD;
      suitable as an alternative to conventional opioid-based regimen in patients undergoing valve&#xD;
      surgery&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High-dose opioid anesthesia during cardiac surgery has been the mainstay of cardiac&#xD;
      anesthesia for decades due to its ability to preserve hemodynamic stability and attenuate&#xD;
      hormonal and metabolic response to surgical stress (1) . However, large doses of long-acting&#xD;
      opioids required patients to be ventilated post-operatively for 12-24 h. Modifications in&#xD;
      these practices have been dictated by the increasing cost, complications of prolonged&#xD;
      mechanical ventilation, and the changes in demographics of patients presenting for cardiac&#xD;
      surgery (2) . Moreover, the intraoperative use of large bolus doses or continuous infusions&#xD;
      of potent opioids may be associated with postoperative hyperalgesia and tolerance (3). When&#xD;
      it comes to ambulatory surgery, opioid related side effects, such as postoperative nausea and&#xD;
      vomiting (PONV), prolonged sedation, ileus and urinary retention may delay recovery and&#xD;
      discharge or cause unanticipated hospital readmission (4) . Such complications might, at&#xD;
      least in part, also apply to cardiac anesthesia.&#xD;
&#xD;
      Recent evidence suggests that increased total dose of opioids during cardiac surgery may lead&#xD;
      to increased in-hospital, as well as long-term post-operative pain medication requirements&#xD;
      for up to one year (5). Moreover, according to Hirji et al study , ongoing opioid use three&#xD;
      months after CABG was present in 21.7% of opioid-exposed patients versus 3.2% of opioid-naive&#xD;
      patients (6). In addition, Opioids have many known side effects such as somnolence, brainstem&#xD;
      and respiratory depression , and chronic opioid dependence (7-9), and there is a national&#xD;
      trend to decrease opioid use during non-cardiac surgery to promote faster recovery and&#xD;
      decrease narcotic use post-operatively (1) .&#xD;
&#xD;
      Several studies demonstrated the effectiveness of Opioid-free Anesthesia (OFA) in patients&#xD;
      undergoing non-cardiac surgery(4,10,11). Preoperative use of COX inhibitors, GABA analogues&#xD;
      and acetaminophen have been shown to decrease use of opioids postoperatively(10).&#xD;
      Intraoperative use of agents that lead to opioid sparing effects via sodium channel blockade,&#xD;
      blockade of G protein-coupled receptors, NMDA blockade, central alpha-2 agonists and&#xD;
      anti-inflammatory effects can make opioid-free anesthesia (OFA) possible (12,13). On the&#xD;
      other hand, there have been no studies demonstrating the effectiveness of an OFA technique in&#xD;
      patients undergoing cardiac surgery except for two case reports who successfully implemented&#xD;
      the OFA regimen in two patients undergoing valve replacement surgeries (14,15). The&#xD;
      investigators therefore propose this prospective randomized controlled trial to investigate&#xD;
      whether a multimodal opioid-free anesthesia regimen will be suitable as an alternative to&#xD;
      conventional opioid-based regimen in patients undergoing valve surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extubation time (min)</measure>
    <time_frame>24 hours</time_frame>
    <description>Extubation time, defined as the time from discontinuation of inhalation agents to extubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate (beats/min)</measure>
    <time_frame>24 hours</time_frame>
    <description>HR&#xD;
o Arterial blood pressure (systolic, diastolic, and mean)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure (mm Hg)</measure>
    <time_frame>24 hours</time_frame>
    <description>Systolic, diastolic, and mean blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative rescue analgesia (number)</measure>
    <time_frame>24</time_frame>
    <description>The number of patients requiring rescue analgesia with Morphine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative morphine consumption (mg)</measure>
    <time_frame>24 hours</time_frame>
    <description>The total dose of morphine administered</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Opioid-Free Anesthesia (OFA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The following drugs will be administered 10 minutes before induction of anesthesia in group I (OFA):&#xD;
Pregabalin 150 mg orally with a small sip of water&#xD;
Acetaminophen 1 gm and Ketorolac 30 mg in 100 mL i.v. over 10 minutes&#xD;
Dexmedetomidine loading dose of 0.5 mic/kg i.v. over 10 minutes&#xD;
Lidocaine loading dose of 1.5 mg/kg i.v. over 10 minutes&#xD;
For simplicity, the weight-based doses of dexmedetomidine and lidocaine will be prepared in a 20 mL syringe&#xD;
the following drugs will be administered as a continuous infusion:&#xD;
Dexmedetomidine 0.5 mic/kg/h&#xD;
Lidocaine 0.5 mg/kg/h&#xD;
Patients in both groups will be extubated when they meet our institutional criteria for extubation. Postoperative analgesia will be started as follows:&#xD;
Group I (OFA):&#xD;
Acetaminophen 1 gm/6h&#xD;
ketorolac 30 mg/8h&#xD;
Pregabalin 150 mg once at night&#xD;
Celecoxib 200 mg/24 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid Anesthesia (OA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Before induction In Group II (OA) patients will receive placebo pills and normal saline in equivalent volumes .&#xD;
Maintenance&#xD;
In Group II (OA) patients will receive a continuous infusion of Fentanyl (1 mic/kg/h)&#xD;
Patients in both groups will be extubated when they meet our institutional criteria for extubation. Postoperative analgesia will be started as follows:&#xD;
â€¢ Morphine 0.1 mg /kg PRN every 8 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.5 mic/kg/h</intervention_name>
    <description>In Group I (OFA) the following drugs will be administered preoperatively:&#xD;
Acetaminophen 1 gm and Ketorolac 30 mg in 100 mL i.v. over 10 minutes Dexmedetomidine loading dose of 0.5 mic/kg i.v. over 10 minutes Lidocaine loading dose of 1.5 mg/kg i.v. over 10 minutes&#xD;
The following drugs will be administered as a continuous infusion throughout the operation:&#xD;
Dexmedetomidine 0.5 mic/kg/h&#xD;
Lidocaine 0.5 mg/kg/h&#xD;
The following drugs will be administered postoperatively:&#xD;
Acetaminophen 1 gm/6h ketorolac 30 mg/8h Pregabalin 150 mg once at night Celecoxib 200 mg/24 hours</description>
    <arm_group_label>Opioid-Free Anesthesia (OFA)</arm_group_label>
    <other_name>Lidocaine 0.5 mg/kg/h</other_name>
    <other_name>Pregabalin 150 mg</other_name>
    <other_name>Acetaminophen 1g</other_name>
    <other_name>Ketorolac 30 mg</other_name>
    <other_name>Celecoxib 200 mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl 1 mic/kg/hr</intervention_name>
    <description>In Group II (OA) patients will receive a continuous infusion of Fentanyl (1 mic/kg/h) Morphine 0.1 mg/kg PRN will be administered every 8 hours for postoperative analgesia</description>
    <arm_group_label>Opioid Anesthesia (OA)</arm_group_label>
    <other_name>Morphine 0.1 mg/kg/hr</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients undergoing cardiac valve surgeries ( replacement or repair ) .&#xD;
&#xD;
          2. Age (18-80) years&#xD;
&#xD;
          3. Both sexes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Known allergy to any of the medications used in the study&#xD;
&#xD;
          -  Combined valve and CABG surgeries&#xD;
&#xD;
          -  Redo surgery&#xD;
&#xD;
          -  Infective endocarditis&#xD;
&#xD;
          -  Patients in heart failure or heart block or with significant systolic dysfunction (EF&#xD;
             &lt; 40%) or diastolic dysfunction more than grade II&#xD;
&#xD;
          -  Pregnant females&#xD;
&#xD;
          -  Patients being treated for chronic pain or with recent use (&lt; two weeks) of opioids,&#xD;
             gabapentin, or pregabalin.&#xD;
&#xD;
          -  Substance abuse&#xD;
&#xD;
          -  Patients with renal impairment (creatinine &gt; 2 mg/dL) or hepatic impairment (ALT &gt; 2&#xD;
             folds, INR &gt; 1.5 and/or serum albumin &lt; 2.5 g/dl)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hossam El-Ashmawi, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hossam el ashmawi, professor</last_name>
    <phone>01001707493</phone>
    <email>h.elashmawi@kasralainy.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ahmed mortada, demonstrator</last_name>
    <phone>01119218956</phone>
    <email>ahmed.m.mortada@kasralainy.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr Al Ainy School of Medicine Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hossam el ashmawi, professor</last_name>
      <phone>01001707493</phone>
      <email>h.elashmawi@kasralainy.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Rong LQ, Kamel MK, Rahouma M, Naik A, Mehta K, Abouarab AA, Di Franco A, Demetres M, Mustapich TL, Fitzgerald MM, Pryor KO, Gaudino M. High-dose versus low-dose opioid anesthesia in adult cardiac surgery: A meta-analysis. J Clin Anesth. 2019 Nov;57:57-62. doi: 10.1016/j.jclinane.2019.03.009. Epub 2019 Mar 11.</citation>
    <PMID>30870677</PMID>
  </reference>
  <reference>
    <citation>Wong WT, Lai VK, Chee YE, Lee A. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2016 Sep 12;9:CD003587. doi: 10.1002/14651858.CD003587.pub3. Review.</citation>
    <PMID>27616189</PMID>
  </reference>
  <reference>
    <citation>Lavand'homme P, Steyaert A. Opioid-free anesthesia opioid side effects: Tolerance and hyperalgesia. Best Pract Res Clin Anaesthesiol. 2017 Dec;31(4):487-498. doi: 10.1016/j.bpa.2017.05.003. Epub 2017 May 17. Review.</citation>
    <PMID>29739537</PMID>
  </reference>
  <reference>
    <citation>Bakan M, Umutoglu T, Topuz U, Uysal H, Bayram M, Kadioglu H, Salihoglu Z. Opioid-free total intravenous anesthesia with propofol, dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a prospective, randomized, double-blinded study. Braz J Anesthesiol. 2015 May-Jun;65(3):191-9. doi: 10.1016/j.bjane.2014.05.001. Epub 2014 Jun 3.</citation>
    <PMID>25925031</PMID>
  </reference>
  <reference>
    <citation>van Gulik L, Ahlers SJ, van de Garde EM, Bruins P, van Boven WJ, Tibboel D, van Dongen EP, Knibbe CA. Remifentanil during cardiac surgery is associated with chronic thoracic pain 1 yr after sternotomy. Br J Anaesth. 2012 Oct;109(4):616-22. doi: 10.1093/bja/aes247. Epub 2012 Jul 24.</citation>
    <PMID>22831889</PMID>
  </reference>
  <reference>
    <citation>Hirji SA, Landino S, Cote C, Lee J, Orhurhu V, Shah RM, McGurk S, Kaneko T, Shekar P, Pelletier MP. Chronic opioid use after coronary bypass surgery. J Card Surg. 2019 Feb;34(2):67-73. doi: 10.1111/jocs.13981. Epub 2019 Jan 9.</citation>
    <PMID>30625257</PMID>
  </reference>
  <reference>
    <citation>Macintyre PE, Walker SM. The scientific evidence for acute pain treatment. Curr Opin Anaesthesiol. 2010 Oct;23(5):623-8. doi: 10.1097/ACO.0b013e32833c33ed. Review.</citation>
    <PMID>20811175</PMID>
  </reference>
  <reference>
    <citation>Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006 Mar;104(3):570-87. Review.</citation>
    <PMID>16508405</PMID>
  </reference>
  <reference>
    <citation>Alam A, Juurlink DN. The prescription opioid epidemic: an overview for anesthesiologists. Can J Anaesth. 2016 Jan;63(1):61-8. doi: 10.1007/s12630-015-0520-y. Epub 2015 Oct 27. Review.</citation>
    <PMID>26507535</PMID>
  </reference>
  <reference>
    <citation>McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs. 2010 Jun 18;70(9):1149-63. doi: 10.2165/10898560-000000000-00000. Review.</citation>
    <PMID>20518581</PMID>
  </reference>
  <reference>
    <citation>James MF. Magnesium: an emerging drug in anaesthesia. Br J Anaesth. 2009 Oct;103(4):465-7. doi: 10.1093/bja/aep242.</citation>
    <PMID>19749114</PMID>
  </reference>
  <reference>
    <citation>Landry E, Burns S, Pelletier MP, Muehlschlegel JD. A Successful Opioid-Free Anesthetic in a Patient Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019 Sep;33(9):2517-2520. doi: 10.1053/j.jvca.2018.11.040. Epub 2018 Nov 28.</citation>
    <PMID>30611614</PMID>
  </reference>
  <reference>
    <citation>Cardinale JP, Gilly G. Opiate-Free Tricuspid Valve Replacement: Case Report. Semin Cardiothorac Vasc Anesth. 2018 Dec;22(4):407-413. doi: 10.1177/1089253218771342. Epub 2018 Apr 20.</citation>
    <PMID>29676223</PMID>
  </reference>
  <reference>
    <citation>Salah M, Hosny H, Salah M, Saad H. Impact of immediate versus delayed tracheal extubation on length of ICU stay of cardiac surgical patients, a randomized trial. Heart Lung Vessel. 2015;7(4):311-9.</citation>
    <PMID>26811837</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 4, 2020</study_first_submitted>
  <study_first_submitted_qc>November 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2020</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Hossam El-Ashmawi</investigator_full_name>
    <investigator_title>Professor of anesthiology and pain management</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

